Latest Early-onset Alzheimer's disease Stories
Mathematical Model Still Needs "Real World" Proof Also, "Resilience Index" May Predict Successful Cognitive Aging - PARIS, July 19, 2011 /PRNewswire-USNewswire/ -- A new mathematical model of global Alzheimer's risk suggests that reducing the prevalence of well-known, lifestyle-based, chronic disease risk factors by 25 percent could potentially prevent 3 million cases of Alzheimer's worldwide, according to new research presented today at the Alzheimer's Association International Conference...
PARIS, July 17, 2011 /PRNewswire-USNewswire/ -- The Alzheimer's Association recognized four leading scientists for their extraordinary contributions to Alzheimer's disease research at the Alzheimer's Association International Conference (AAIC 2011) in Paris, France.
Researchers at the RIKEN Brain Science Institute (BSI) and their collaborators have shed light on the function of a little-studied amyloid peptide in promoting Alzheimer's disease (AD).
Researchers at the Sahlgrenska Academy, University of Gothenburg, have identified a series of novel proteins in human cerebrospinal fluid.
The second most common cause of degenerative Parkinsonism is a devastating disease that currently has no available treatment.
The Spanish conquistadors dreamed of gold in the hills of Colombia. In the 21st century, a new breed of explorer is in hot pursuit of a treasure far more precious: a way to prevent or cure Alzheimerâ€™s disease.
Higher levels of cell chatter boost amyloid beta in the brain regions that Alzheimerâ€™s hits first, researchers at Washington University School of Medicine in St. Louis report.
Itâ€™s been 27 years since the clinical diagnostic criteria for Alzheimer's disease has been revised.
Areas of the brain affected by Alzheimer's disease (AD) may start shrinking up to a decade before dementia is diagnosed, according to a new study.
Mount Sinai School of Medicine researchers are part of a consortium that has identified four new genes that increase the risk of a person developing Alzheimer's disease later in life.
- A transitional zone between two communities containing the characteristic species of each.